BrainScan
BrainScan S.A. is a Poland-based medical AI company that develops deep learning software detecting 30+ brain pathologies in non-contrast CT scans, serving hospitals, emergency departments, and radiology centers across Europe with expansion into the US market.
- Company typePublic
- Founded2017
- HeadquartersGdansk, Poland
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What BrainScan does
BrainScan S.A. is a Polish medical AI company founded in 2017 and headquartered in Gdańsk that develops deep learning software for automated detection and triage of brain pathologies in non-contrast CT scans. Its core product, BrainScan CT, uses proprietary convolutional neural networks trained on a database of over 350,000 CT examinations to detect 30 key brain pathologies including hemorrhages, ischemic strokes, and tumors, and generates standardized summary graphics that are embedded directly into DICOM files for seamless integration with hospital PACS workflows. The system is CE MDR 2017/745 certified in the EU and FDA-certified in the US, with a US patent (US 20250272830A1) protecting its DICOM-embedded anomaly detection and summary image generation method. Independent peer-reviewed validation has reported AUC of 0.930 for acute ischemic stroke detection and AUC of 0.983 for hemorrhage detection.
The company serves three primary customer segments: acute care hospitals and emergency departments requiring rapid CT triage, radiology departments and imaging centers seeking AI-assisted interpretation and standardized reporting, and medical education institutions using the BrainScan EDU training platform. The company is publicly listed on the Warsaw Stock Exchange NewConnect market (ticker BSN) following a May 2024 IPO, and is operating across Poland, Germany, Ukraine, Bulgaria, Morocco, and Tunisia. BrainScan generates revenue through multi-year software licensing contracts (typically 36 months) sold via direct enterprise sales and public procurement tenders in Poland, supplemented by distribution partnerships with Synektik (medical imaging), Carebot s.r.o. (Central Europe), and Healthcare Konnect (North Africa), and marketplace revenue share through CARPL.AI's global radiology AI platform.
The business model centers on per-site enterprise licensing of the BrainScan CT system with both cloud and on-premise deployment options, priced through individual public tenders with disclosed contract values typically ranging from €30K to €60K per multi-year engagement. The company has signed strategic partnerships with Aidoc and upmedic to co-develop integrated clinical decision support offerings and has research collaborations with LMU Klinikum München and Provincial Hospital in Poznan for clinical validation. Current strategic priorities include US market entry following FDA certification, expansion of the multimodal diagnostic platform into contrast-enhanced CT analysis and tumor detection (funded by a €2.64M PARP grant running Q1 2025 to Q2 2027), and an active strategic options review initiated in January 2026 to explore mergers, partnerships, or investor transactions aimed at accelerating commercial growth toward profitability.
BrainScan firmographics
Firmographics- Name
- BrainScan
- Legal name
- BrainScan S.A.
- Website
- https://brainscan.ai
- Company type
- Public
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- BrainScan S.A. is a Poland-based medical AI company that develops deep learning software detecting 30+ brain pathologies in non-contrast CT scans, serving hospitals, emergency departments, and radiology centers across Europe with expansion into the US market.
- Ownership category
- akta.pro rank
BrainScan industry classification
Industry- Product category
- Radiology AI Software
- NAICS
- Medical and Diagnostic Laboratories (62151), Diagnostic Imaging Centers (621512)
- SIC
- Services-Prepackaged Software (7372), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Medical Imaging AI (HDAAAEAH)
- akta.pro secondary industries
- Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ), Diagnostic & Triage Decision Support (HLACAGAA)
Keywords
Where BrainScan is headquartered
LocationHeadquarters
- HQ city
- Gdansk
- HQ country
- Poland
- HQ region
- Europe
Offices2 records
Markets served
BrainScan business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Software Licensing: AI-powered diagnostic software licensing to hospitals and healthcare institutions. Software is deployed either on-premise or cloud-based, with hospitals purchasing licenses for BrainScan CT system. Revenue generated from license fees, typically structured as multi-year contracts (36-month terms common in public tenders).
- Public Tenders and Procurement: Direct sales through public procurement tenders in Poland and internationally. Winning hospital tenders for AI diagnostic systems and educational platforms. Notable contracts include 36-month license agreements with Polish hospitals.
- Educational Platform Licensing: Specialized AI-based education platform (Brainscan EDU) for medical education and training in brain CT scan analysis. Deployed in hospital settings for training young physicians and radiologists in training.
- Marketplace Revenue Share: Revenue sharing arrangement through CARPL.AI marketplace platform. BrainScan receives upper few tens of percent of revenues from each transaction involving BrainScan CT system through the platform.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Enterprise Hospital License |
Go-to-market motion4 records
Distribution channels5 records
Marketing channels5 records
BrainScan product offering
Product offeringCore offering
BrainScan develops AI-powered diagnostic software that automatically analyzes non-contrast head CT scans to detect 30 brain pathologies including hemorrhages, ischemic strokes, and tumors. The BrainScan CT system provides instant triage alerts to emergency physicians and generates DICOM-embedded standardized summary images for radiologists, deployed either on-premise or via cloud in hospitals and radiology centers.
Product overview
BrainScan offers a unified AI-powered diagnostic platform centered on BrainScan CT, the core product for automated brain CT analysis and clinical decision support. The portfolio includes Brainscan EDU, an educational add-on module for medical training, and an in-development multimodal diagnostic platform expanding into contrast-enhanced CT and tumor detection. The company operates primarily as an on-premise or cloud-deployed software solution, with integrations into third-party platforms like CARPL.AI.
Differentiator
Problem solved
Functional benefit
Brands
- BrainScan CT: AI-powered system for automated brain CT analysis and detection of brain pathologies
- BrainScan EDU
Products and services
- BrainScan CT AI-powered diagnostic system for automated detection and analysis of brain pathologies in CT scans, providing real-time triage and clinical decision support for radiologists and emergency physicians. Detects 30 brain pathologies including hemorrhages, strokes, and tumors, and generates DICOM-embedded standardized summary images.
- BrainScan EDU Educational AI platform for brain CT imaging that supports structured learning, case-based education, and decision support for young physicians in training and experienced radiologists. Deployed in hospital and academic settings for radiology residency programs.
Quantifiable outcome
- Time to radiologist report reduced by up to 30%
- +5 more outcomes
Companies that use BrainScan
Customer profileNamed customers7 records
Segments3 records
Ideal customer profiles3 records
BrainScan technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability5 records
Feature5 records
BrainScan partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered minor and core.
- Healthcare KonnectminorPartnership with Healthcare Konnect for BrainScan participation in 25th Franco-Tunisian Radiology Days in Djerba, Tunisia. Collaboration supports growth of modern medical imaging and digital healthcare transformation across North African region.
- Carebot s.r.o.coreStrategic distribution agreement covering deployment and commercial expansion of BrainScan CT system in Central Europe. Carebot's strong regional footprint and established customer base create conditions for introducing BrainScan to hospitals and medical networks in new markets. Complementary product portfolios enable comprehensive radiology AI suite offering.
- SynektikcoreStrategic distribution partnership making BrainScan AI solution for CT brain imaging available through Synektik, a leading provider of medical imaging technologies. Partnership strengthens presence in medical imaging market and brings AI-driven diagnostic support to more healthcare institutions.
- AidoccoreStrategic partnership with global leader in AI-powered medical imaging solutions headquartered in Tel Aviv, Israel. Represents major milestone in mission to revolutionize clinical decision-making through cutting-edge technology and intelligent diagnostics. Collaboration advances AI-driven clinical decision support capabilities.
- CARPL.AIcoreIntegration partnership making BrainScan CT system available through CARPL.AI's global digital marketplace for radiology AI. Platform aggregates diverse AI models for radiology and enables rapid deployment to healthcare providers. BrainScan receives upper few tens of percent of revenues from each platform transaction. Partnership duration 3 years with termination rights for breach.
- LMU Klinikum MünchencoreInternational research collaboration with Ludwig Maximilian University Hospital in Munich for clinical validation and refinement of upcoming features including automated report generation planned for 2026. Supports FDA certification and US market entry strategy.
- Provincial Hospital in PoznancoreScientific research collaboration with Provincial Hospital in Poznan supporting clinical validation and product development. Partnership generates real-world evidence and testimonial for system effectiveness in emergency settings.
- upmediccoreStrategic partnership between BrainScan and upmedic delivering complete AI-powered solution for brain CT diagnostics. Collaboration creates fully integrated, end-to-end solution by combining BrainScan's advanced technology with upmedic's capabilities.
Scale indicators6 records
Recent moves12 records
Expansion highlights6 records
BrainScan competitors and assessment
Company assessmentDirect peers
- Avicenna.AI: AI company focused on radiology workflow and triage, with overlapping neuro and emergency imaging use cases. Directly comparable as a smaller, specialty radiology AI vendor serving hospitals.
- Aidoc: Global leader in AI-powered medical imaging headquartered in Tel Aviv. Both companies provide AI-driven radiology decision support, and Aidoc is also a named BrainScan partner, making it the most directly comparable peer in terms of product surface, customer type, and go-to-market.
- Viz.ai: Specialist in AI-driven stroke triage and neurovascular workflow. Competes head-to-head in the same emergency neuro CT use case BrainScan targets and serves similar hospital emergency and radiology departments.
- RapidAI: AI platform for stroke and brain imaging triage and analytics. Highly comparable in clinical workflow focus (acute ischemic and hemorrhagic stroke) and customer base of stroke-ready hospitals and radiology departments.
- Qure.ai: AI radiology company with FDA-cleared products across head CT, chest, and lung workflows. Direct overlap with BrainScan in brain CT detection (hemorrhage, stroke) and similar enterprise hospital sales motion.
- icometrix: Specialist in AI-based brain MRI and CT quantification, focused on neurology. Direct competitor in brain-specific imaging AI, with overlapping neuroscience and radiology customer segments.
- Annalise.ai: Comprehensive radiology AI platform covering head CT and other modalities, competing for the same enterprise radiology and emergency department customers.
- deepc: AI radiology operating system and marketplace; also a named BrainScan collaborator (LMU Munich deployment). Direct overlap in distributing third-party radiology AI models to hospitals through a marketplace model.
Emerging players
- Subtle Medical: AI medical imaging company focused on image enhancement and workflow acceleration. Adjacent rather than direct competitor in brain CT triage, but operates in the same hospital AI procurement budgets and conferences.
Others
- CARPL.AI: Global digital marketplace for radiology AI models. Listed as a distribution and integration partner rather than competitor, but is a key ecosystem enabler and revenue-share counterpart for BrainScan.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
BrainScan social profiles
Digital presenceBrainScan compliance and trust
Trust signalCompliance2 records
BrainScan financial estimates
Financial estimateRevenue estimate
Valuation estimate
BrainScan leadership team
Management profileNumber of profiles
Profiles8 records
BrainScan funding detail
Funding detailFunding overview
Funding rounds6 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BrainScan M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BrainScan
What does BrainScan do?
BrainScan develops AI-powered diagnostic software that automatically analyzes non-contrast head CT scans to detect 30 brain pathologies including hemorrhages, ischemic strokes, and tumors. The BrainScan CT system provides instant triage alerts to emergency physicians and generates DICOM-embedded standardized summary images for radiologists, deployed either on-premise or via cloud in hospitals and radiology centers.
Is BrainScan a public or private company?
BrainScan is a public company. It is classified as public and is currently operating.
When was BrainScan founded?
BrainScan was founded in 2017. It employs 11 to 50 people.
Where is BrainScan based?
BrainScan is headquartered in Gdansk, Poland, in the Europe region.
How does BrainScan make money?
Four revenue lines are on record. Software Licensing is the primary driver. The others are public Tenders and Procurement, educational Platform Licensing and marketplace Revenue Share.
Who are BrainScan's main competitors?
Direct peers on record are Avicenna.AI, Aidoc, Viz.ai, RapidAI, Qure.ai, icometrix, Annalise.ai and deepc. Subtle Medical is listed as an emerging player. CARPL.AI is listed as an others.
Does BrainScan have an API?
No public API is recorded for BrainScan.
What industry is BrainScan in?
BrainScan's product category is Radiology AI Software. Its primary akta.pro industry code is HDAAAEAH, Medical Imaging AI, with a secondary code of HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software. Its NAICS code is 62151 and its SIC code is 7372.